Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Zurita, Amado J.
Danziger, Natalie
Scott, Takara
Gjoerup, Ole
Zhong, Lei
Tukachinsky, Hanna
Ross, Jeffrey S.
Graf, Ryon
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Fdn Med Inc, Cambridge, MA USA
[3] SUNY Upstate Med Univ, Syracuse, NY USA
[4] Fdn Med Inc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.455
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
455
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [31] PATTERNS OF CARE IN AUSTRALIAN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (mRCC)
    Dai, D.
    Kanjanapan, Y.
    Kwan, E.
    Yip, D.
    Lawrentschuk, N.
    Andrews, M.
    Davis, I. D.
    Azad, A.
    Rosenthal, M.
    Wong, S.
    Arifeen, S.
    Alam, M.
    Gibbs, P.
    Tran, B.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 54 - 54
  • [32] Association of circulating tumor cells (CTCs) with immune checkpoint inhibitor (ICI) responses in metastatic renal cell carcinoma (mRCC)
    Zhang, T.
    Poellmann, M.
    Park, S-J.
    Bu, J.
    Zhao, R.
    Zhou, Q.
    Agarwal, A.
    Parks, J.
    Reyes-Martinez, M.
    Armstrong, A. J.
    George, D. J.
    Wang, A. Z.
    Hong, S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1221 - S1221
  • [33] Prognostic role of circulating tumor cells-CTCs in metastatic renal cell carcinoma.
    Basso, Umberto
    Facchinetti, Antonella
    Rossi, Elisabetta
    Maruzzo, Marco
    Conteduca, Vincenza
    Aieta, Michele
    Massari, Francesco
    Fraccon, Anna Paola
    Mucciarini, Claudia
    Sava, Teodoro
    Santoni, Matteo
    Pegoraro, Maria Cristina
    Durante, Emilia
    Nicodemo, Maurizio
    Perin, Alessandra
    Bearz, Alessandra
    Pasini, Felice
    Gatti, Carlo
    Zamarchi, Rita
    Zagonel, Vittorina
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Prognostic value of VHL gene alteration in patients with metastatic renal cell carcinoma
    Nosovt, D. A.
    Yakovleva, E. S.
    Fedyanin, M. Yu.
    Chekini, D. A.
    Sinitsyna, M. N.
    Savelov, N. A.
    Mikhailenkoc, D. S.
    Zaletayevc, D. V.
    Lyubchenkol, L. N.
    Tjulandini, S. A.
    ONKOUROLOGIYA, 2011, 7 (03): : 47 - 56
  • [35] Prognostic value of sarcopenia in metastatic renal cell carcinoma patients: A systematic review
    Tancherla, A.
    Wijovi, F.
    Halim, D. A.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1322 - S1322
  • [36] Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma
    Marta, Guilherme Nader
    Velho, Pedro Isaacsson
    Bonadio, Renata R. C.
    Nardo, Mirella
    Faraj, Sheila F.
    de Azevedo Souza, Manoel Carlos L.
    Muniz, David Q. B.
    Bastos, Diogo Assed
    Dzik, Carlos
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2489 - 2497
  • [37] Prognostic ability of HR-QoL parameters in metastatic renal cell carcinoma (mRCC)
    Gruenwald, V.
    Dietrich, M.
    Pond, G. R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] The Role of Circulating Tumor DNA in Renal Cell Carcinoma
    Paulo G. Bergerot
    Andrew W. Hahn
    Cristiane Decat Bergerot
    Jeremy Jones
    Sumanta Kumar Pal
    Current Treatment Options in Oncology, 2018, 19
  • [39] The Role of Circulating Tumor DNA in Renal Cell Carcinoma
    Bergerot, Paulo G.
    Hahn, Andrew W.
    Bergerot, Cristiane Decat
    Jones, Jeremy
    Pal, Sumanta Kumar
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (02)
  • [40] The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma
    Boerlin, Aurelio
    Bellini, Elisa
    Turko, Patrick
    Cheng, Phil F.
    Levesque, Mitchell P.
    Dummer, Reinhard
    Ramelyte, Egle
    CANCERS, 2022, 14 (17)
12345